Goldman Sachs Adjusts Price Target on Revvity
Goldman Sachs increased its price target for Revvity, Inc. from $140 to $160.
Stocks · News reference
Analysts Adjust Price Targets for Revvity Following Q3 Earnings
Multiple financial institutions, including Stifel Nicolaus, Goldman Sachs, and JPMorgan, updated their price targets for Revvity on November 4, 2026, following the company's third-quarter earnings report.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up
Revvity (RVTY) reported Q3 2026 adjusted EPS of $1.38, beating estimates by 7%, with revenues rising 4.3% to $728.9M. Life Sciences revenues climbed 10.7% driven by strong pharma and biotech demand. The company raised its 2026 pro forma EPS guidance to $5.40-$5.45 and revenue forecast to $2.86B, reflecting 6% total growth and 5% organic growth.
8-K filing — REVVITY, INC. (RVTY)
Filed: 2026-11-03 AccNo: 0000031791-26-000031 Size: 871 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Revvity Reports Q3 2026 Financial Results
Revvity, Inc. reported third-quarter 2026 financial results, exceeding analyst expectations for both revenue and adjusted earnings per share.
Revvity Board Declares Quarterly Dividend
Revvity, Inc. has declared a regular quarterly dividend of $0.07 per share of common stock.
TD Cowen Maintains Buy on Revvity, Raises Price Target to $175
TD Cowen analyst Dan Brennan maintains Revvity (NYSE:RVTY) with a Buy and raises the price target from $130 to $175.